tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Balance Sheet

184 Followers

Keros Therapeutics Balance Sheet

Keros Therapeutics's total assets for Q3 2023 were $326.25M, a decrease of -8.43% from the previous quarter. KROS total liabilities were $30.41M for the fiscal quarter, a 1.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 306.78M$ 255.25M$ 269.44M$ 10.96M$ 27.41M
Total Liabilities
$ 29.36M$ 12.08M$ 7.72M$ 10.46M$ 14.65M
Total Equity Gross Minority
$ 277.42M$ 243.17M$ 261.72M$ 495.00K$ 12.76M
Total Capitalization
$ 290.23M$ 243.17M$ 261.72M$ 495.00K$ 12.76M
Preferred Stock Equity
---$ 19.94M$ 19.94M
Capital Lease Obligations
--$ 899.00K$ 1.27M$ 788.00K
Currency in USD

Keros Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis